5-oxo-N-pentyl-5-(2-sulfanylidene-1,3-thiazolidin-3-yl)pentanamide

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 5-oxo-N-pentyl-5-(2-sulfanylidene-1,3-thiazolidin-3-yl)pentanamide
• 化学式: C₁₃H₂₂N₂O₂S₂
• 分子量: 302.5
• InChiKey: QIZUFEDVGCGAMX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  19
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.77
• 拓扑面积：
  107
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• MACROCYCLES
  申请人：THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

  公开号：US20150157746A1

  公开（公告）日：2015-06-11

  The invention provides macrocycles useful in chelating metal ions, particularly radionuclides, to provide metal ion complexes. The invention also provides methods of using the compounds and complexes of the invention, such as in therapeutic and diagnostic applications.

  这项发明提供了在螯合金属离子中特别是放射性核素中有用的大环化合物，以提供金属离子配合物。该发明还提供了使用这些化合物和配合物的方法，例如在治疗和诊断应用中。
• [EN] MACROCYCLIC LIGANDS WITH PENDANT CHELATING MOIETIES AND COMPLEXES THEREOF<br/>[FR] LIGANDS MACROCYCLIQUES AYANT DES FRACTIONS CHÉLATANTES PENDANTES ET LEURS COMPLEXES
  申请人：LUMIPHORE INC

  公开号：WO2018045385A1

  公开（公告）日：2018-03-08

  The invention relates to chemical compounds and complexes that can be used in therapeutic and diagnostic applications.

  该发明涉及可用于治疗和诊断应用的化学化合物和配合物。
• [EN] THIOHYDROXYPYRIDINE CHELATES<br/>[FR] CHÉLATES DE THIOHYDROXYPYRIDINE
  申请人：LUMIPHORE INC

  公开号：WO2022087317A1

  公开（公告）日：2022-04-28

  There is a provided metal ion chelating agents capable of stably binding soft Lewis acid metal ions, metal ion chelates based on these chelating agents, and methods of using the compounds of the invention in diagnostic and therapeutics methods. Also provided are methods of sequestering soft Lewis acid metal ions. Exemplary soft Lewis acid metal ions are radionuclides.

  提供了一种金属离子螯合剂，能够稳定地结合软路易斯酸金属离子，基于这些螯合剂的金属离子螯合物，并且提供了使用该发明中化合物进行诊断和治疗方法的方法。还提供了隔离软路易斯酸金属离子的方法。软路易斯酸金属离子的示例是放射性核素。
• LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES
  申请人：RAYMOND Kenneth N.

  公开号：US20120329174A1

  公开（公告）日：2012-12-27

  The present invention provides a novel class of macrocyclic compounds as well as complexes formed between a metal (e.g., lanthanide) ion and the compounds of the invention. Preferred complexes exhibit high stability as well as high quantum yields of lanthanide ion luminescence in aqueous media without the need for secondary activating agents. Preferred compounds incorporate hydroxy-isophthalamide moieties within their macrocyclic structure and are characterized by surprisingly low, non-specific binding to a variety of polypeptides such as antibodies and proteins as well as high kinetic stability. These characteristics distinguish them from known, open-structured ligands.

  本发明提供了一类新型的大环化合物，以及由金属（例如镧系金属）离子和本发明化合物形成的配合物。优选的配合物在无需二次激活剂的情况下，在水介质中表现出高稳定性和高镧系离子荧光量子产率。优选的化合物在其大环结构中包含羟基异苯酰胺基团，并以出人意料的低非特异性结合多种多肽（如抗体和蛋白质）以及高动力学稳定性为特征。这些特征使它们与已知的开放结构配体有所区别。
• DI-MACROCYCLES
  申请人：LUMIPHORE, INC.

  公开号：US20160221971A1

  公开（公告）日：2016-08-04

  The invention relates to chemical compounds and complexes that can be used in therapeutic and diagnostic applications.

  本发明涉及可用于治疗和诊断应用的化合物和复合物。